Cite

HARVARD Citation

    Abdel-Qadir, H. et al. (2021). Cardiovascular Risk Associated With Ibrutinib Use in Chronic Lymphocytic Leukemia: A Population-Based Cohort Study. Journal of clinical oncology. 39 (31), pp. 3453-3462. [Online]. 
  
Back to record